Skip to main content
. 2016 Sep 10;7(43):69649–69665. doi: 10.18632/oncotarget.11935

Figure 6. CDCP1 expression in human primary TNBCs.

Figure 6

(A) FFPE TNBC sections were immunostained with polyclonal anti-CDCP1 (Thermo Fisher Scientific), and membrane staining intensity was scored as positive or negative as described in Materials and Methods. Scale bar: 50 μm (insets 2×). (B) Frequency distribution of human specimens by percentage of CDCP1-positive cells.